Brands
Dabur dons Kovirakshak kit, as ASCI doffs Chyawanprash ad
Mumbai: India’s leading FMCG major Dabur India Limited Tuesday announced the launch of Dabur Kovirakshak Kit that includes Chyawanprash, Giloy, Tulsi and Juri-Tap products.
A company message said the product is “A combination of time-trusted ayurvedic medicines to help in faster recovery from ongoing respiratory infections. Dabur KoviRakshak Kit was developed and launched based on (the) Indian Council of Medical Research (ICMR) guidelines and after (a) thorough study on infected patients”, the company has claimed.
@DaburIndia launches ‘Dabur Kovi Rakshak Kit’, a combination of time-trusted Ayurvedic Medicines that help in faster recovery from ongoing respiratory infections. #Dabur #KoviRakshakKit has been developed, launched based on ICMR guidelines and thorough study on infected patients. pic.twitter.com/N4MBnC1MXo
— Dabur India Ltd (@DaburIndia) May 25, 2021
The company’s website also prominently claims: “Get your Dabur Kovirakshak kit – As part of our commitment to fight the COVID-19 pandemic, Dabur is distributing free Kovirakshak kits to the first 200 people who register with us. Sign up to get your immunity shield.”
The new audience interactive advertisement comes only a day after the Advertising Standards Council of India (ASCI) pulled up the brand for making misleading claims through its advertisement for Dabur Chyawanprash. ASCI had asked the ayurveda major to modify or withdraw the Chyawanprash ad that claimed to offer protection against the Corona virus. The print ad published in March this year claimed that taking two spoons of the product daily provided protection against COVID-19.
ASCI secretary general Manisha Kapoor told IndianTelevision that while she’s yet to see the new Dabur Kovirakshak ad, “Each product and advertisement will have to be examined on its own merit, if they are able to prove what they are claiming then its fine.” She added that they have not received any complaint about the newer advertisement so far.
The ad featuring actor Akshay Kumar stated that the claim is backed by “clinical studies conducted in 5 centres”.
The advertisement ran into controversy on social media after several people tagged ASCI to look into the matter. Brand consultant & strategist, Ambi Parameswaran had also tweeted and alerted ASCI about a possible violation:
Alerting @ascionline ! How reliable and valid is the study @DaburIndia is quoting? Please find out and pass your verdict. @rameshnarayan @skswamy @beastoftraal @calamur @bhatnaturally Two spoons vs Two shots of vaccine? pic.twitter.com/UgKAc2MZxn
— Ambi Parameswaran (@ambimgp) March 26, 2021
ASCI launched an investigation after a formal complaint was lodged and noted, “Dabur Chyawanprash has immunity building properties, however, it is not established whether the product could protect one against (the) Corona virus.”
In its report to Dabur, as reported by online media afaqs, ASCI stated that the claim made in the advertisement “could be construed literally by an ordinary consumer, that consuming the product would protect one from COVID-19”. Following the investigation of reports and data provided by Dabur, the Consumer Complaints Council (CCC) of ASCI in turn maintained that the “claim is misleading by ambiguity and exaggeration and is likely to lead to widespread disappointment in the minds of consumers.”
ASCI has advised Dabur to suitably modify or withdraw the advertisement by June 4, 2021.
The ad had attracted major trolling on social media after its brand ambassador Akshay Kumar announced that he has tested positive for covid-19.
— Akshay Kumar (@akshaykumar) April 4, 2021
The irony of the situation was not lost on net users who trolled the brand as well as the actor over the apparently false COVID-19-protection claims.
A section of the online community had also red flagged the actor and the company for being reckless while promoting products through incorrect claims.
#AkshayKumar becomes #Coronapositive .
But, isn’t he one who advertises a chyawanprash promising protection against #COVIDー19 ?
Will advertising council now make the actor announce that he doesn’t consume the product?#dabur#coronavirus#@ascionline @DaburIndia pic.twitter.com/t1eHl6TYj3— Adwait Ainapure (@adwaitainapure) April 4, 2021
While the Covid-19 outbreak has brought some businesses to a grinding halt, it has also served as a business opportunity for others. Several FMCG giants cashed in on the health-related fear induced into the general public by the pandemic by launching a plethora of immunity-boosting products ranging from beverages comprising of juice, tea, coffee to probiotic shots and supplements in capsule form, mixes and powder, even food items.
The Indian Immunity Boosting Packaged Products Market is projected to reach $ 347 million by FY 2026, as per a report, owing to increasing consciousness and focus among Indian consumers towards sickness preventing health foods.
Major players operating in the immunity boosting packaged products market include The Himalaya Drug Company, Dabur India Ltd., Patanjali Ayurved, among others, which have capitalised on their ayurvedic lineage. Dabur India is a remarkable case in point, with the home-grown FMCG major overhauling its go-to-market strategy.
While Brand strategist Ambi Parameshwaran believes the brand has played it safe this time by avoiding any blatant mention of COVID-19 protection in the ad copy, he still feels the product name may get it into trouble once again. He said, “Just on the basis of the name Kovirakshak Kit they can be taken to ASCI again. Rakshak in Hindi means protector, which again implies COVID-19 protection, not just immunity. So, while the copy is correct, I still have an issue with the brand name. They could be hauled up once again.”
In either case, the controversy has meant piqued audience interest inadvertently for a second time, not necessarily in the interest of public health. Bad publicity is also good for publicity.
Brands
Netflix India names Rekha Rane director of films and series marketing
Streaming giant bets on a seasoned marketer who helped build Amazon and Netflix into household names
MUMBAI: Netflix has put a proven brand builder at the helm of its films and series marketing in India, naming Rekha Rane as director in a move that signals sharper focus on audience growth and cultural cut-through in one of its most hotly contested markets.
Rane steps into the role after seven years at Netflix, where she has quietly shaped how the platform sells stories to India. Her latest promotion, effective February 2026, crowns a run that spans brand, slate and product marketing across originals, licensed content and new verticals such as games.
A strategic marketing and communications professional with roughly 15 years’ experience, Rane has spent much of her career building technology-led consumer businesses and new categories, notably e-commerce and subscription video on demand. She was part of the early push that introduced Amazon.in, Prime Video and Netflix to Indian homes, then helped turn them into everyday brands.
At Netflix, she most recently served as head of brand and slate marketing for India from March 2024 to February 2026, leading teams across media and marketing for global and local content portfolios. Before that, as manager for original films and series marketing, she led IP creation and go-to-market strategy for titles including Guns and Gulaabs, Kaala Paani, The Railway Men* and The Great Indian Kapil Show, spanning both binge and weekly-release formats.
Her earlier Netflix roles covered product discovery and promotion in India and integrated campaign strategy to drive conversations around the content slate, product awareness and brand-equity metrics.
Before Netflix, Rane logged more than three years at Amazon in brand marketing roles in Bengaluru. There she handled national and regional campaigns for Amazon.in, worked on customer assistance programmes in growth geographies and contributed to the go-to-market strategy for the launch of Prime Video India.
Her career began well away from streaming. At Reliance Brands in Mumbai, she worked on retail marketing for Diesel and Superdry. A stint at Leo Burnett saw her work on primary research for P&G Tide, mapping Indian shoppers’ paths to purchase. Earlier still, at Orange in the United Kingdom, she rose from sales assistant to store manager, running a team and owning monthly P&L for a retail outlet.
The arc is telling. As global streamers fight for attention in a crowded Indian market, executives who understand both mass retail behaviour and digital habit-building are prized. Rane’s career sits at that intersection.
For Netflix, the bet is simple: in a market spoilt for choice, sharp marketing can still tilt the screen. And with Rane now leading the charge, the streamer is signalling it wants not just viewers, but fandom.
Brands
Orient Beverages pops the fizz with steady Q3 gains and rising profits
Kolkata-based beverage maker reports stronger revenues and profits for December quarter.
MUMBAI: A fizzy quarter with a steady aftertaste that’s how Orient Beverages Limited, the company that manufactures and distributes packaged drinking water under the brand name Bisleri closed the December 2025 period, as the Kolkata-based drinks maker reported improved revenues and a healthy rise in profits, signalling operational stability in a competitive beverage market.
For the quarter ended December 31, 2025, Orient Beverages posted standalone revenue from operations of Rs 39.98 crore, up from Rs 36.42 crore in the previous quarter and Rs 33.53 crore in the same quarter last year. Total income for the quarter stood at Rs 42.24 crore, reflecting consistent demand and stable pricing across its beverage portfolio.
Profit before tax for the quarter came in at Rs 3.47 crore, a sharp improvement from Rs 1.31 crore in the September quarter and Rs 0.39 crore a year ago. After accounting for tax expenses of Rs 0.79 crore, the company reported a net profit of Rs 2.68 crore, nearly three times the Rs 0.99 crore recorded in the preceding quarter.
On a nine-month basis, the momentum remained intact. Revenue from operations for the period ended December 31, 2025 rose to Rs 117.66 crore, compared with Rs 106.95 crore in the corresponding period last year. Net profit for the nine months climbed to Rs 5.51 crore, more than double the Rs 2.18 crore reported in the same period of the previous financial year.
The consolidated numbers told a similar story. For the December quarter, consolidated revenue from operations stood at Rs 45.06 crore, while profit after tax came in at Rs 2.06 crore. For the nine-month period, consolidated revenue touched Rs 133.57 crore, with net profit of Rs 4.49 crore, underscoring the group’s improving profitability trajectory.
Operating expenses remained largely controlled, with cost of materials, employee benefits and other expenses broadly aligned with revenue growth. The company continued to operate within a single reportable segment beverages simplifying its cost structure and reporting framework.
The unaudited financial results were reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on 7 February 2026. Statutory auditors carried out a limited review and reported no material misstatements in the results.
In a market where margins are often squeezed by input costs and competition, Orient Beverages’ latest numbers suggest the company has found a reliable rhythm not explosive, but steady enough to keep the fizz alive.
Brands
BCCL profit jumps 53 per cent in FY25 as tax bill shrinks
Revenue rises 4.3 per cent to Rs 10,209.33 crore while deferred tax gain lifts bottom line sharply
NEW DELHI: Bennett, Coleman and Company (BCCL) has posted a sparkling set of financial results for the year ended 31 March 2025, proving that there is still plenty of ink and gold left in the ledger.
Revenue from operations climbed a steady 4.3 per cent, reaching Rs 10,209.33 crore compared to Rs 9,786.44 crore the previous year. When you sprinkle in other income, which rose 8.9 per cent to Rs 949.36 crore, the total income for the media behemoth hit a healthy Rs 11,158.69 crore.
While the income grew at a modest pace, the bottom line tells a far more dramatic story. The real headline is the 53 per cent surge in annual profit. How did they pull off such a feat? While Profit Before Tax (PBT) saw a gentle nudge upward of 2.7 per cent to Rs 1,610.00 crore, it was a vanishing act by the taxman that really did the trick.
Total tax expenses plummeted by 32.4 per cent, dropping from Rs 468.76 crore down to Rs 316.97 crore. This was largely thanks to a swing in deferred tax, moving from an expense of Rs 156.02 crore in FY24 to a benefit of Rs 39.44 crore this year.
Total income rose from Rs 10,658.55 crore in FY24 to Rs 11,158.69 crore in FY25, marking a 4.7 per cent increase. Total expenses grew at a slower pace, up 3.0 per cent from Rs 9,306.06 crore to Rs 9,581.45 crore. Profit before tax inched up 2.7 per cent, moving from Rs 1,567.02 crore to Rs 1,610.00 crore. However, the standout figure was net profit, which jumped sharply by 53.0 per cent, climbing from Rs 1,042.03 crore in FY24 to Rs 1,594.73 crore in FY25.
Despite the rising costs of doing business across the globe, BCCL kept a tight grip on the purse strings. Total expenses rose by just 3.0 per cent to Rs 9,581.45 crore. By keeping costs lower than the rate of income growth, the company ensured that the final figure, a net profit of Rs 1,594.73 crore, was nothing short of a front-page sensation.
In a world of shifting digital tides, it seems the BCCL ship is not just steady, but sailing into significantly wealthier waters.
-
e-commerce3 weeks agoSwiggy Instamart’s GOV surges 103 per cent year on year to Rs 7,938 crore
-
News Broadcasting2 weeks agoMukesh Ambani, Larry Fink come together for CNBC-TV18 exclusive
-
News Headline1 month agoFrom selfies to big bucks, India’s influencer economy explodes in 2025
-
iWorld5 months agoBillions still offline despite mobile internet surge: GSMA
-
News Headline2 months ago2025: The year Indian sports saw chaos, comebacks, and breakthroughs
-
Applications2 months ago28 per cent of divorced daters in India are open to remarriage: Rebounce
-
News Headline2 weeks agoJioStar announces biggest ever talent line-up for an ICC event
-
News Headline2 months agoGame on again as 2025 powers up a record year and sets the stage for 2030


